Advanced nanovaccines based on engineering nanomaterials for accurately enhanced cancer immunotherapy

Dandan Wang, Wenxing Gu, Weiliang Chen, Jin Zhou, Le Yu, Byung Kook Kim, Xuenong Zhang, Jong Seung Kim

Research output: Contribution to journalReview articlepeer-review


In recent years, nanovaccine based on nanomaterials emerging as an advanced nanotechnology has drawn more attention for accurately enhancing anti-tumor immunotherapy. Nanovaccine loaded with antigen and immunopotentiator could stimulate antigen presenting cells (APCs) to release signals of co-stimulatory cytokines and reinvigorate the immune-killing T cell to alleviate tumor progression. The amplification of co-stimulatory markers has the potential to enhance the sensitivity of APCs towards tumor neoantigens. Furthermore, positive regulation via nanovaccine of antigen-dependent APCs with a “self-promoting” effect with more recruits of immune-killing T cells could contribute to potentiating the presentation and processing of antigen, finally improving the efficacy of immunotherapy. Of note, if the intracellular and exocellular delivery of antigen could be effectively manipulated, the well-designed nanovaccine will provide a platform for clinical therapeutic practice. In this review, we summarize the development, technical advantages and challenges of nanovaccine in the multi-stage delivery process for immune-guided therapeutic efficacy.

Original languageEnglish
Article number214788
JournalCoordination Chemistry Reviews
Publication statusPublished - 2022 Dec 1


  • Antigen delivery
  • Antigen presentation processing
  • Cancer immunotherapy
  • Dendritic cells-targeting
  • Immune activations
  • Nanovaccine

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Inorganic Chemistry
  • Materials Chemistry


Dive into the research topics of 'Advanced nanovaccines based on engineering nanomaterials for accurately enhanced cancer immunotherapy'. Together they form a unique fingerprint.

Cite this